Assenagon Asset Management S.A. Ocular Therapeutix, Inc Transaction History

Assenagon Asset Management S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$4.83 - $7.35 $66,142 - $100,650	-13,694 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$6.16 - $12.07 $36,362 - $71,249	-5,903 Reduced 30.12%	13,694 $95,000
Q3 2021 Oct 19, 2021	SELL	$9.7 - $14.34 $750,944 - $1.11 Million	-77,417 Reduced 79.8%	19,597 $196,000
Q2 2021 Jul 15, 2021	BUY	$13.43 - $19.16 $15,028 - $21,440	1,119 Added 1.17%	97,014 $1.38 Million
Q4 2020 Feb 01, 2021	BUY	$7.91 - $22.95 $758,529 - $2.2 Million	95,895 New	95,895 $1.99 Million

151

136M

86.4K

263K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $668M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.